U.S. Markets closed

Ironwood Pharmaceuticals, Inc. – Value Analysis (NASDAQ:IRWD) : October 16, 2017

CapitalCube
Capital Cube
Ironwood Pharmaceuticals, Inc. – Value Analysis (NASDAQ:IRWD) : October 16, 2017

Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Ironwood Pharmaceuticals, Inc. a score of 47. Our analysis is based on comparing Ironwood Pharmaceuticals, Inc. with the following peers – Progenics Pharmaceuticals, Inc., Synergy Pharmaceuticals, Inc., Nektar Therapeutics, Astrazeneca PLC Sponsored ADR, Sucampo Pharmaceuticals, Inc. Class A, Cumberland Pharmaceuticals Inc. and Synthetic Biologics, Inc. (PGNX-US, SGYP-US, ... Read more (Read more...)